Home › Trial NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients
- Trial IDNCT05429866
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorJules Bordet Institute
- Enrollment441
- Start date2022-09-01
- ConditionsBreast Cancer · Melanoma · Non Small Cell Lung Cancer · Non-melanoma Skin Cancer · Gastrointestinal Cancer · Head and Neck Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.